Moxifloxacin HCl
Moxifloxacin hydrochloride is an advanced fourth-generation fluoroquinolone. It exhibits a unique dual mechanism of action by binding tightly to both DNA gyrase and topoisomerase IV, significantly lowering the rate of bacterial resistance development while providing excellent coverage against atypical and respiratory pathogens.
Respiratory Tract Infections
Bacterial Sinusitis
Pneumonia
and Certain Skin Infections
Respiratory Tract Infections
Bacterial Sinusitis
Pneumonia
and Certain Skin Infections
High Purity & Efficacy
USP / BP / EP / IP Grade Compliance
Stringent Quality Control & Batch Consistency
Pharmaceutical Formulations
Oral Solid Dosage (Tablets & Capsules)
Sterile Formulations / Injectables (where applicable)
Custom API Compounding